Prosecution Insights
Last updated: October 04, 2026

Korus Patent, LLC

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

9 pending office actions • 8 clients • 9 examiners • 7 art units • 0 of 9 (0%) have an AI response strategy ready

Analysis

KORUS Patent, LLC focuses its practice on Medical Devices & Mechanical Engineering, having managed 863 career applications. The firm has achieved a resolved allowance rate of 79.17 percent, which demonstrates the proportion of its applications that reach a grant. This record of 863 career applications serves as the basis for the firm's experience in the mechanical and medical device sectors.

Prosecution at the firm is characterized by an average of 2.1 office actions per allowance. This figure shows the typical number of interactions between the firm and examiners before a patent is allowed. Currently, the firm has 6 pending office actions, indicating its active workload within the Medical Devices & Mechanical Engineering area. These 6 pending office actions are fewer than the 863 career applications on record.

The 863 career applications and 79.17 percent allowance rate establish the firm's historical performance. The 2.1 office actions per allowance provide a benchmark for the expected duration of the prosecution process. The 6 pending office actions represent the firm's immediate focus as it continues to manage its clients' patent portfolios.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=863 apps, methodology: how we score firms)

79.2%
Allowance Rate
n=863
+0.49σ
Allowance Rate (norm)
n=863
2.1
OAs to Allowance
n=627
-0.75σ
OAs to Allow (norm)
n=627
769 days
Time to Allowance
n=627
+9.1pp
Interview Lift
n=863
13.9%
RCE Rate
n=863
1.8%
Appeal Rate
n=863

Rejection Performance (% of received rejections ultimately overcome)

65.5%
§101 Overcome
n=84
72.4%
§102 Overcome
n=246
72.3%
§103 Overcome
n=447
72.9%
§112 Overcome
n=402

Specialization & Scale

G06F, G06Q, H04R
Top CPC Subclasses
9%
Top-3 CPC Share
n=863
1
Practitioners
n=863
863.0
Apps / Practitioner
n=863

Portfolio Summary

9
Total Pending OAs
7
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (67%)
1
Medium (11%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (22%)
§112 only2 (22%)
Double-patenting + other1 (11%)
Multi-statute (no §101)4 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
22% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
56% of docket
2
Business / Other
22% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SEGED, NEBYATE SAMUEL 1 31.3% +49.3%
MOSS, NATALIE M 1 30.8% +17.1%
KIM, ERIN ASA 1 70.1% +33.2%
TEJANI, ANKIT D 1 81.0% +16.9%
CHAVCHAVADZE, COLLEEN MARGARET 1 57.3% +40.4%
TOICH, SARA KATHERINE 1 50.0% +47.1%
O'BRIEN, LEA S 1 51.4% +13.9%
JENNISON, BRIAN W 1 71.9% +22.0%
DARRIGRAND, EMILY ANN 1 — —

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18169318 COFFEE MAKER JENNISON, BRIAN W 37d overdue
18461870 HEALTH-PROMOTING FUNCTIONAL SHOE HAVING FUNCTION OF STIMULATING SOLAR PLEXUS POINT TOICH, SARA KATHERINE 22d
18624742 MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR TEJANI, ANKIT D 26d
18795800 PLASMA AIR PURIFYING APPARATUS SEGED, NEBYATE SAMUEL —
18141239 IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN O'BRIEN, LEA S —
17909866 METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE DARRIGRAND, EMILY ANN —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18169318 COFFEE MAKER JENNISON, BRIAN W 37d overdue
18461870 HEALTH-PROMOTING FUNCTIONAL SHOE HAVING FUNCTION OF STIMULATING SOLAR PLEXUS POINT TOICH, SARA KATHERINE 22d
18624742 MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR TEJANI, ANKIT D 26d
18795800 PLASMA AIR PURIFYING APPARATUS SEGED, NEBYATE SAMUEL —
18727799 COMPOSITION FOR CULTRING NK CELLS, COMPRISING ALLOFERON, AND METHOD FOR CULTURING NK CELLS USING SAME MOSS, NATALIE M —
18700353 BODY-WORN URINAL FOR FEMALE PATIENT KIM, ERIN ASA —
18614968 MULTIPURPOSE SLIDING APPARATUS CHAVCHAVADZE, COLLEEN MARGARET —
18141239 IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN O'BRIEN, LEA S —

Client Portfolio (8 clients)

Top Art Units

Art UnitApps
37811
37961
36341
37851
16461
37611
16861

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18795800 PLASMA AIR PURIFYING APPARATUS Junsys Co., Ltd. SEGED, NEBYATE SAMUEL §103§112 Non-Final OA — Pending Aug 06, 2024
18727799 COMPOSITION FOR CULTRING NK CELLS, COMPRISING ALLOFERON, AND METHOD FOR CULTURING NK CELLS USING SAME Nk Medics Inc. MOSS, NATALIE M §102§103§112DP Non-Final OA — Pending Jul 10, 2024
18700353 BODY-WORN URINAL FOR FEMALE PATIENT Mediruns Co., Ltd. KIM, ERIN ASA 3781 §112 Non-Final OA — Pending Apr 11, 2024
18624742 MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR Techcord Co., Ltd. TEJANI, ANKIT D 3796 §102§103Other Non-Final OA 26d Pending Apr 02, 2024
18614968 MULTIPURPOSE SLIDING APPARATUS Hankook Rail System Co., Ltd. CHAVCHAVADZE, COLLEEN MARGARET 3634 §112 Final Rejection — Pending Mar 25, 2024
18461870 HEALTH-PROMOTING FUNCTIONAL SHOE HAVING FUNCTION OF STIMULATING SOLAR PLEXUS POINT Shoealls Co., Ltd. TOICH, SARA KATHERINE 3785 §103§112 Final Rejection 22d Pending Sep 06, 2023
18141239 IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN Theragen Bio Co., Ltd. O'BRIEN, LEA S 1646 §101§103§112 Non-Final OA — Pending Apr 28, 2023
18169318 COFFEE MAKER Hugh Inc. JENNISON, BRIAN W 3761 §103§112 Non-Final OA 37d overdue Pending Feb 15, 2023
17909866 METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE Theragen Bio Co., Ltd. DARRIGRAND, EMILY ANN 1686 §101§103§112 Non-Final OA — Pending Sep 07, 2022

Managing Korus Patent, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month